Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients.
about
Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
P2860
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Computerized patient identific ...... static breast cancer patients.
@ast
Computerized patient identific ...... static breast cancer patients.
@en
type
label
Computerized patient identific ...... static breast cancer patients.
@ast
Computerized patient identific ...... static breast cancer patients.
@en
prefLabel
Computerized patient identific ...... static breast cancer patients.
@ast
Computerized patient identific ...... static breast cancer patients.
@en
P2093
P2860
P50
P1476
Computerized patient identific ...... static breast cancer patients.
@en
P2093
Andreas Hartkopf
Christina Barbara Walter
Debra Lounsbury
Diana Lüftner
Erik Belleville
Friedrich Overkamp
Hans Tesch
Hans-Christian Kolberg
Johannes Ettl
Markus Wallwiener
P2860
P2888
P356
10.1007/S10549-016-3850-8
P407
P50
P577
2016-06-09T00:00:00Z
P6179
1046923303